Columns - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Columns

Regulatory Watch

Key government and regulatory developments affecting biopharmaceutical and pharmaceutical manufacturers. From Washington Editor Jill Wechsler
View Regulatory Watch

Sean Milmo

European Regulatory Watch

Government, regulatory, and market developments affecting biopharmaceutical and pharmaceutical manufacturers in Europe. From European Correspondent Sean Milmo:
View European Regulatory Watch

Outsourcing Outlook

Insights into trends and challenges facing contract service providers and users in the pharmaceutical and biopharmaceutical industries from outsourcing pros Jim Miller and Eric Langer.
View Outsourcing Outlook

Global News

Global correspondents report on industry trends and markets around the world. Plus: learn what companies are doing to improve global healthcare on the ground and to strengthen their corporate social responsibility (CSR) and sustainability.

API Synthesis and Manufacturing

The latest business and scientific developments in manufacturing active pharmaceutical ingredients, intermediates, and excipients.
View API Synthesis and Manufacturing


Packaging Forum

Coverage of packaging equipment, containers, systems, and materials from pharmaceutical packaging expert Hallie Forcino.
View Packaging Forum

Editors' Forum

From the Editor perspectives and PharmTech Talk by PharmTech editors, and guest editorials offer perspectives on the industry.

Viewpoints

Pharmaceutical industry members and associations, including PhRMA, BIO, and GPhA, share their views on the issues impacting pharmaceutical manufacturers and their suppliers.
View Viewpoints

Inside Standards

Exclusive insider observation and analysis from standard-setting and regulatory organizations, including USP, IPEC, ICH, PIC/S, and more. Plus, Susan J. Schniepp provides Insider Solutions for key compendial and QA/QC challenges.
View Inside Standards

Statistical Solutions

Chris Burgess, PhD, evaluates and analyzes relevant statistical methods for the pharmaceutical industry.
View Statistical Solutions

Industry Insider

An update on the latest issues, regulations and trends affecting pharmaceutical manufacturers.
View Industry Insider

View Archives of Previously Published Columns
Book Review
Agent-in-Place
Coming Down the Pike
Faiz Kermani's Spotlight


ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here